Prognostic Impact of Time to Ipsilateral Breast Tumor Recurrence after Breast Conserving Surgery

• Marie Gosset,

  Affiliation Department of Surgery, Institut Curie, 75005, Paris, France

  ⨯
• Anne-Sophie Hamy,

  Affiliation Department of Surgery, Institut Curie, 75005, Paris, France

  ⨯
• Peter Mallon,

  Affiliation Breast Unit, Belfast City Hospital, Lisburn Road, Belfast, BT9 7AB, Northern Ireland

  ⨯
• Myriam Delomenie,

  Affiliation Department of Surgery, Institut Curie, 75005, Paris, France

  ⨯
• Delphine Mouttet,

  Affiliation Department of Surgery, Institut Curie, 75005, Paris, France

  ⨯
• Jean-Yves Pierga,

  Affiliations Department of Medical Oncology, 75005, Institut Curie, Paris, France, Paris Descartes University, 75006, Paris, France

  ⨯
• Marick Lae,

  Affiliation Department of Tumor Biology, Institut Curie, 75005, Paris, France

  ⨯
• Alain Fourquet,

  Affiliation Department of Radiotherapy, Institut Curie, 75005, Paris, France

  ⨯
• Roman Rouzier,

  Affiliation Department of Surgery, Institut Curie, 75005, Paris, France

  ⨯
• Fabien Reyal ,

  * E-mail: fabien.reyal@curie.fr

  Affiliations Department of Surgery, Institut Curie, 75005, Paris, France, Residual Tumor and Response to Treatment Lab, Translational Research Department, Institut Curie, 75005, Paris, France, UMR932 Immunity and Cancer, INSERM, Institut Curie, 75005, Paris, France

  ⨯
• Jean-Guillaume Feron

  Affiliation Department of Surgery, Institut Curie, 75005, Paris, France

  ⨯